Autotransfusion Blood Bags Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Autotransfusion Blood Bags Market is segmented By Type (300ml Capacity, 600ml Capacity, 700ml Capacity, 1000ml Capacity), By Application (Cardiac Surgery, Non-Cardiac Surgery), and By Region (North America, Europe, South America, Asia-Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Autotransfusion Blood Bags Market Overview

The "Global Autotransfusion Blood Bags Market" is predicted to reach a high CAGR during the forecast period (2023-2030).

Autotransfusion is the process where a person receives their blood for a transfusion instead of separate donor blood. Autotransfusion blood bags refer to a disposable blood bag, which is used for blood autotransfusion.

Autotransfusion Blood Bags Market Scope

To Know More Insights - Download Sample

Autotransfusion Blood Bags Market Dynamics

Increasing the number of road traffic accidents is a major factor driving the market's growth.

According to the statpearls, on 31 July 2021, Trauma continues to be the predominant cause of death for individuals up to 44 years old. 1.2 million deaths were reported due to road traffic crashes in 2018 globally. Even though traumatic brain injury is the leading cause of death from Trauma, exsanguination plays a significant role. For patients who arrive at the emergency department for Trauma, hemorrhage is the leading cause of death. Within the first 24 hours of approaching the emergency department, nearly 50% of deaths result from bleeding.

Moreover, Trauma patients also require large amounts of hospital resources and are responsible for using approximately 70% of all blood transfused at a trauma center. In addition, the goal of autotransfusion remains the same, to maintain a sterile field, prevent clotting of the collected blood, filtration of the blood, and administer the patient. Thus, from the above statements to the increasing number of road traffic accidents, the demand for autotransfusion increases, expected to drive the market's growth in the forecast period.

Complications that occurred by the autotransfusion of the blood are expected to get hampered in the forecast period.

According to the statpearls, they were published on 31 July 2021. Autotransfusion has not always been a safe procedure. The most common complication is blood loss if not properly connected. A common decision is chest tube placement, in which blood is expressed and then wasted. Moreover, the more serious complication includes blood contamination resulting in infection. Although the indications may be comparatively straightforward, it is important to note that numerous contraindications can result in serious consequences if ignored. The main important thing to know is whether the blood has suffered contamination. Contamination can present as an infectious vs. non-infectious source. Infectious contamination happens to any penetrating chest wound that may have violated the diaphragm and involved the gastrointestinal tract. Other sources of contamination include non-infectious causes. The use of blood from a site where a sterile solution is mixed with the blood (e.g., iodine, sterile water, alcohol, irrigation solutions, or chlorhexidine) is not avoided. In addition, other less common complications include hemodilution, hemolysis due to degradation, air embolism, contamination of activated leukocytes, and thrombocytopenia. Thus, from the above statements, the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has caused considerable morbidity and mortality worldwide and has profoundly disrupted healthcare systems and society. The pandemic has had major implications for blood supply and demand, posing organizational and logistical challenges for transfusion services essential for public health, and healthcare systems are under pressure. Frequent, regular transfusion therapy in hospital clinics can be enervating for patients and time-consuming and burdensome both for them and their caregivers and families – impairing their quality of life.

The impact varies between countries, depending on the epidemiology of COVID-19 and other factors, including the prevalence of transfusion-dependent chronic conditions. Moreover, the pandemic is interrupting the medical supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. However, the situation is expected to improve gradually in the forecast period.

Autotransfusion Blood Bags Market Segment Analysis

The cardiac surgery segment is expected to hold the largest market share in this market segment.

The cardiac surgery segment accounted for the largest market share in 2020, according to the PLOS ONE journal, March 10, 2021. Intra-operative autologous blood donation is a blood conservation technique with limited evidence. They evaluated the association between intra-operative autologous blood donation and decreased peri-operative transfusion in cardiovascular surgery based on evidence from a Japanese administrative database.

Moreover, they extracted the data of patients who had undergone cardiovascular surgery from the Diagnosis Procedure Combination database in Japan (2016–2019). Based on the surgery type, they examined the association of intraoperative autologous blood donation with the transfusion rate and amount of blood used in cardiac and aortic surgeries using multilevel propensity score matching. They enrolled 32,433 and 4,267 patients who underwent cardiac and aortic surgeries and received 5.0% and 6.7% intra-operative autologous blood donation with mean volumes of 557.68 mL and 616.96 mL, respectively. The red blood cell transfusion rates of the control and intra-operative autologous blood donation groups were 60.6% and 38.4%, respectively, in the cardiac surgery cohort (p < .001) and 91.4%, and 83.8%, respectively, in the aortic surgery cohort (p = .037). The transfusion amounts for the control and intra-operative autologous blood donation groups were 5.9 and 3.5 units of red blood cells, respectively, for cardiac surgery patients and 11.9 and 7.9 units, respectively, for aortic surgery patients. Therefore, the number of red blood cells and fresh frozen plasma for patients undergoing index cardiovascular surgery and could be an effective blood transfusion strategy in cardiovascular surgery for Japanese patients. Thus, the market segment is expected to hold the largest market segment in the forecast period from the above statements.

Autotransfusion Blood Bags Market Geographical Share

North America region holds the largest market share in the global autotransfusion blood bags market.

North America dominated the market and led to the largest revenue share in 2020. The region's growth is attributed to increased awareness about blood transfusion and its benefits; an increasing number of surgeries and medical procedures are expected to boost the market in the forecast period. For instance, according to the Texas Heart Institute, Thousands of heart surgeries are performed every day in the United States. Even though there is a lack of donor organs, more than 3,400 people have heart transplants each year. Coronary Artery Bypass is the most common heart surgery, also called coronary artery bypass graft surgery (CABG). The surgery involves using a healthy section of blood vessel from another part of the body to bypass a part of a diseased or blocked coronary artery. It creates a new route for blood to flow so that the heart muscle will get the oxygen-rich blood it needs to work properly.

The breastbone (sternum) is divided during bypass surgery, the heart is stopped, and there is a huge amount of blood loss, where the blood is sent through a heart-lung machine or autotransfusion machine. Therefore, due to the increase in cardiovascular surgeries, there is an increase in the demand for autotransfusion machines which is expected to hold the largest market share in the North American region in the forecast period.

Autotransfusion Blood Bags Market Companies

The autotransfusion blood bags market is vast with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Atrium Medical, Fresenius, Teleflex, Medtronic, Weigao Medical International Co., Ltd. and Suzhou Industrial Park Winwin Import & Export Co., Ltd. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the autotransfusion blood bags market globally.

Autotransfusion Blood Bags Market Key Companies to Watch

Medtronic plc:

Overview:

Medtronic plc. is an American-Irish registered medical device company that primarily operates in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson&#39;s disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

Medtronic plc. has continuously set new standards for the manufacturing of products including autoLog® Autotransfusion System and auto log IQ™ autotransfusion system.

The global autotransfusion blood bags market report would provide an access to an approx.35 market data tables, 36 figures and 180 pages.